Brian W. Adams Acquires 5,391 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock
Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CFO Brian W. Adams purchased 5,391 shares of Tabula Rasa HealthCare stock in a transaction dated Friday, January 12th. The stock was bought at an average price of $14.23 per share, with a total value of $76,713.93. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Tabula Rasa HealthCare Inc (TRHC) traded up $0.54 during trading on Thursday, reaching $34.21. The company had a trading volume of 30,493 shares, compared to its average volume of 282,094. Tabula Rasa HealthCare Inc has a twelve month low of $11.59 and a twelve month high of $36.80. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73. The stock has a market capitalization of $656.21 and a PE ratio of -201.24.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Monday, November 6th. The company reported $0.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.02. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business had revenue of $33.27 million during the quarter, compared to analysts’ expectations of $31.76 million. During the same period in the previous year, the business earned $0.06 earnings per share. The firm’s revenue was up 37.6% on a year-over-year basis. equities research analysts predict that Tabula Rasa HealthCare Inc will post 0.03 EPS for the current year.
TRHC has been the subject of several recent research reports. Zacks Investment Research cut Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research report on Friday, November 10th. Piper Jaffray Companies restated an “overweight” rating and set a $29.00 target price (up from $20.00) on shares of Tabula Rasa HealthCare in a research report on Wednesday, September 20th. Wells Fargo & Co boosted their target price on Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a research report on Thursday, October 19th. BidaskClub cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Friday, December 15th. Finally, Citigroup began coverage on Tabula Rasa HealthCare in a research report on Thursday, January 4th. They set a “buy” rating for the company. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Tabula Rasa HealthCare presently has a consensus rating of “Buy” and a consensus price target of $29.78.
TRADEMARK VIOLATION NOTICE: “Brian W. Adams Acquires 5,391 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2018/01/18/brian-w-adams-acquires-5391-shares-of-tabula-rasa-healthcare-inc-trhc-stock.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.